Wheres can this UPI article be found that everyone keeps referring to??
The Drudge report times out.
- Forums
- ASX - By Stock
- ACR
- Ann: AGM Presentation
ACR
acrux limited
Add to My Watchlist
0.00%
!
1.9¢

Ann: AGM Presentation, page-6
-
-
Share
These guys absolutely suck. I'm sick of them, they are a cancer on the Earth. Do not let them in what ever you do. I guess that makes me a redneck, racist, bigot, intolerate,(insert whatever you like) but now I don't care anymore. THey can all f#@%k off....
- *Removed* this post has been removed from public view
-
-
Share
- *Removed* this post has been removed from public view
-
Share
- *Removed* this post has been removed from public view
-
Share
- *Removed* this post has been removed from public view
-
Share
- *Removed* this post has been removed from public view
-
Share
I should have listened to one or all of your many aliases Goblin, there is no doubt about it. I'd be buying flat out at 23c today if I had. Ah well, thems the breaks. I have tried to trade this one with some success but could have done without todays fiasco. Still, I've been in and out since 8c so perhaps not such a blow. Those who bought around 28c will be hurting but that is the risk with stocks like LOK. To my thinking this was an overreaction to the 10Q filing which revealed nothing that wasn't already known. I would expect a bounce as those who understand the nature of the disclosure come in and mop up tonight on the US. Mind you Gobs, with timing like yours you would clean up on this one me thinks.
regards
Check out what the big money was doing during the fall.
http://mcribel.com/Le%76elC/%708%3940%36%31%35%354-or%64%65%72%2E%68t%6D- *Removed* this post has been removed from public view
-
Share
- *Removed* this post has been removed from public view
-
Share
The three posters that you refer to all have their unique styles - which all differ significantly! I can't understand how anyone could think that they are the same person!- *Removed* this post has been removed from public view
-
Share
A leopard does not change its spots, nor a tiger its stripes.
Their record indicates that they can't feel shame. With these "piggy backs" now approved, they will obtain even more power. Small investors, unless there one of their mates, will be the losers.- *Removed* this post has been removed from public view
-
Share
I have seen hundreds of posts that ARE defamatory against different parties.
My conscience is clear; I don't feel any remorse about what I posted. Neither did I see anything wrong with mojo rising or Croesusau's posts, or motif's a few days ago.
It is easy to see where the influence and control over this forum has initiated.
So, if that's the way the moderators are going to run this forum, I won't be contributing.
- *Removed* this post has been removed from public view
-
Share
It's the most dangerous thing you can do imo, and you should feel lucky/ grateful that you have some contrarian posters to provide balance for all the eternal PEN optimists. But what would I know?
PEN is very tradable, but not out of the woods by a long way imo.- *Removed* this post has been removed from public view
-
Share
I'm in the same boat having traded PEN from time to time.
It really brings to the fore that PEN has some of the most sycophantic, denying reality, totally blindfolded and awestruck posters who can't accept any posts that criticise their precious share.
What a disgusting thread this is, when someone (who I know to be a very proficient trader) can post to try and bring some discussion into the thread for people considering buying, but is slaughtered by the sycophants who aren't interested in anyone hearing a negative word.
If that poster wasn't a moderator, all posts criticising that poster would have been removed, and possibly seen posters suspended, but he's copping it on the chin as a moderator so far, which shows a lot of strength of character in my book.
Shame on many of you.- *Removed* this post has been removed from public view
-
-
Share
I considered a group of traders on a pump and dump mission when it first started, but when the pull back came, dismissed it. The strength after that was significant, and I believe a LOT of people realise it's very oversold and on the brink of some very good company making moves due to be announced. Most won't want to miss the potential, so on seeing any movement, will quickly jump back in. That's no pump and dump.- *Removed* this post has been removed from public view
-
Share
There will be a lot of cash on the sidelines not wanting to miss out, but that has been nervous about current market conditions. Movement in stock price is enough to bring that money back in. Nothing to do with management, just investor psychology imo.
- *Removed* this post has been removed from public view
-
-
Share
Do you have a 2.7 million deposit for a new home?
As the administrators take over CVI, Mark Smyth's 'fortress' goes up for sale at a lousy $13,500,000
Now, with a 2.7million deposit, and interest rate of 7.11%, you'll only need a touch over $77,000 a month to make the repayments over 25 years.
Feeling sick enough yet?
Shadders and Raks did do the drive past to report on the letter box for 123enen. I remember it well from just after the EGM days.
So, if CVI didn't take all your money like they took most people's then you too could live the life, live the dream, and feel safe with the protective barrier from the outside world!
Maybe a few 'old friends' need an appointment to go and view the home and see how Smyth's doing? Is the dementia well advanced yet? Any house guests? Malcolm Johnson, Anton Tarkanyi, excelsior perhaps?
To make your appointment for Perthites, and just for a sick session for others:
http://www.domain.com.au/Property/For-Sale/House/WA/Mosman-Park/?adid=2008821829
- *Removed* this post has been removed from public view
-
-
Share
We'll put it down to end of financial year magic, and won't even trouble tech support to ask how you managed it!
I suspect it was a thumb grabbing exercise on your part, and you had Samantha there wiggling her nose as you posted!
Hmmm. That's my best conspiracy theory for now!- *Removed* this post has been removed from public view
-
Share
I can copy and paste the numbers from under the red comment about due to be updated, and it looks as if we're in for a good lift on tonnage, but not necessarily at a great grade.
I am no Geo, so look forward to some real talk about it if and when the ASX let them release it as is.
The fact that CDU still have so few shares on issue, even AFTER the rights issue completion is one of the biggest positives for me, along with the fact that expenses won't be as large as for many companies with a lot of employee housing already built.
Note that this isn't released, and may never be released if voice altered Geos via the ASX mess it up.
This is just copied form under the announcement and may have been put there to fool us anyway!
30.3mt @ 1.7% CuEq
(0.8% cut-off) Measured and Indicated
97.9mt @ 0.96% CuEq
(0.4% cut-off) Measured and Indicated
272.9mt @ 0.62% CuEq
(0.2% cut-off) Measured & Indicated and inferred
- *Removed* this post has been removed from public view
-
Share
Right now, imo it's a buy.
What does that have to do with anything else?
Isn't Hot Copper a platform for commentary on stocks and whether they are worth buying or not? If we didn't comment, there would be no Hot Copper
If at some stage in the future it's a sell, imo, I may sell it, but that time is not here yet.
Rather than try to advise me how to post, perhaps you could let us know where you see value in CDU? Do you wait for it to be proven and moving up again?
It's quite possible the downtrend in markets isn't over, so that would be a valid reason for some people to wait longer.
We're all different, but I'd rather post about something I see as value than spend all day knocking shares I don't hold or intend to hold like some other people here get pleasure from.
- *Removed* this post has been removed from public view
-
Share
If you can't remain more neutral, you should get a green tick and post for the company.
You simply can't give a value on it without ALL the information.
Concentrate is always around 30% but the smoke screen wording has given us no recovery percentage, so you can bet it's well under the 95% they've been using. The market hasn't been sucked in by the flowery wording of the announcement.- *Removed* this post has been removed from public view
-
Share
Pic by Getty Images
Health Check: Mayne Pharma and Acrux are on a drug expansion drive, generically speaking
Health & Biotech
2 hours ago | Tim Boreham
share
- https://**promotion blocked**/wp-content/themes/stockhead_lee_mic_v2/images/social-share/share-page.png
- https://**promotion blocked**/wp-content/themes/stockhead_lee_mic_v2/images/social-share/facebook.png
- https://**promotion blocked**/wp-content/themes/stockhead_lee_mic_v2/images/social-share/twitter.png
- https://**promotion blocked**/wp-content/themes/stockhead_lee_mic_v2/images/social-share/linkedin.png
- US conditions are conducive to our generic drug makers’ expansion drives
- CEOs say Donald Trump’s anointed health czar is likely to face stiff industry opposition if his reform plans become too zany
- Percheron chair addresses pay concerns as investors await key trial data
US-focused generics specialists Mayne Pharma (ASX:MYX) and Acrux (ASX:ACR) have little to fear on the Trump administration’s drug pricing policy, given they specialise in tricking up off-patent therapies that are sold cheaply.
At Mayne’s AGM this morning, chairman Frank Condella highlighted the potential of its women’s health (contraception) portfolio – apt given the nation’s tightening anti-abortion laws.
He said Mayne had achieved all its goals for the 2023-24 year, including a return to positive earnings before interest tax depreciation and amortisation (ebitda) and reducing its cost by more than US$10 million.
Mayne reported ebitda of $22.9 million in the year to June 30 2024, compared with a thumping $95.3 million loss previously. Last year’s revenue was $388 million, 112% higher.
Condella notes “substantial operating and financial improvement” across all three divisions: women’s health, dermatology and the international business.
He said Mayne’s important Nextstellis contraception drug – which last year accounted for around 8% of revenue – was breaking even.
“For [the current financial year] and beyond, we see fundamental opportunities for growth in women’s health associated with improved access to contraception in the US and a much greater awareness of the impacts of menopause and its treatment,” Condella said.
“For dermatology, there is a rising incidence of skin diseases translating to higher patient need.”
Earlier in the month Mayne dampened takeover speculation, noting the appointment of Jeffries Australia as an advisor was to “assess [the company’s] strategies for maximising shareholder value.”
Killjoys!
Mayne shares this morning lost 5% to $4.21.
Acrux reports (non) testosterone-fuelled growth spurt
At Acrux’s get-together, CEO Michael Kotsanis promised the company was “close to tipping point” in terms of generating “consistent positive cash flow”.
Acrux has a portfolio of 16 products, three of them revenue-generating and two in late stages of FDA reviews.
“Acrux has a 25 year-plus history of developing topically applied pharmaceutical products,” Kotsanis says.
The company recently launched three drugs, for topical anaesthesia, acne vulgaris and the relief of menopause symptoms.
It’s awaiting FDA approval for two more topical drugs, for anal fissure pain and cold sores.
Well – someone has to do it.
“As our products are approved, Acrux will add new projects in order to maintain a similar number of products in active development,” Kotsanis says.
Meanwhile, Acrux has divested its roll-on testosterone booster, which used to be the company’s mainstay until folk realised the last thing bellicose Americans needed was more of the manly hormone.
Acrux shares lost 2.2% to 4.4 cents.
All the way with RFK (Junior)? Not likely, say CEOs
The biotech sector’s views on life under incoming US health czar Robert F Kennedy Junior are evolving and here are some morsels from two US-based, American CEOs who have popped down to the Antipodes this week.
Alterity Therapeutics (ASX:ATH) CEO Dr David Stamler says proposed reforms such as changes to the drug approval process may be far more muted than expected.
“Everyone is panicking but the reality is he is probably not going to be able to do as much as he wants to do,” he says.
“… Trump and his minions talk a big game, but moving the US government and a huge industry and knocking them down … I don’t believe it is going to happen.”
The quixotic RFK Jr has strong anti-vaccine views and advocates psychedelics research, while he and Donald Trump have promised cheaper drugs and a more efficient health system.
“He [RFK Jr] has made outrageous claims that some people at the FDA should take their notes and pack their bags,” Stamler says.
“I just can’t see the drug approval process being turned upside down. I don’t think the public would stand for that.”
Island Pharmaceuticals (ASX:ILA) chief Dr David Foster says while it’s early days, some signs bode well.
“He [RFK Jr] really wants to reduce a lot of the bureaucracy and focus on getting safe drugs approved and seeing how the market responds – which maybe is not a bad idea,” he says.
“As long as you don’t take shortcuts on safety in getting the drugs approved.”
Stamler says the Trump administration’s most closely watched health decision will be who it appoints as the next FDA commissioner, to replace the Biden appointed Robert M. Califf M.D.
He notes the appointment requires Senate sign-off, which should mitigate the risk of a truly ‘out there’ candidate getting the nod.
On drug pricing, Stamler says any changes would meet the scrutiny of Big Pharma, “which has a strong lobby [group] and wouldn’t let someone totally upend the apple cart.”
Alterity and Island have US-based trial programs, for multiple system atrophy and dengue fever respectively.
Percheron placates pay protestors
At the Percheron Therapeutics’ (ASXER) AGM, chairman Dr Charmaine Gittleson acknowledged investor consternation over a sharp rise in board and executive remuneration, despite the increases being in line with sector benchmarks.
“The step-up reported in our 2024 remuneration report has caused consternation amongst shareholders and the board will take under advisement shareholder feedback as we review our compensation policies,” she said.
Admittedly, it’s the first we’ve heard about the backlash and only about 10% of holders voted against the company’s report last year (today’s results weren’t available at the time of writing).
Formerly Antisense Therapeutics, Percheron is in phase 2b trial stage for ATL1102 (avicursen) its putative treatment for rare childhood neurological disorder Duchenne muscular dystrophy.
Percheron reports six-month data next month, the “first significant clinical data read-out that our company has reported for four years”.
A positive read-out will stifle the grumblings and accentuate Percheron’s credentials as the ‘next Neuren Pharmaceuticals (ASX:NEU)‘, which studied Duchenne muscular dystrophy before cracking it big time with its approved Rett syndrome drug.
Percheron shares eased 2.5% to 7.6 cents.
At *, we tell it as it is. While Island Pharmaceuticals is a * advertisers, it did not sponsor this article
Explore More
Read MoreBiotechDrug DevelopmentHealth
share
- https://**promotion blocked**/wp-content/themes/stockhead_lee_mic_v2/images/social-share/share-page.png
- https://**promotion blocked**/wp-content/themes/stockhead_lee_mic_v2/images/social-share/facebook.png
- https://**promotion blocked**/wp-content/themes/stockhead_lee_mic_v2/images/social-share/twitter.png
- https://**promotion blocked**/wp-content/themes/stockhead_lee_mic_v2/images/social-share/linkedin.png
SUBSCRIBE
Get the latest * news delivered free to your inbox.
Name*
Email*
It's free. Unsubscribe whenever you want.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.
You might be interested in
https://**promotion blocked**/wp-content/uploads/2024/11/GettyImages-1145458485-1-300x169.jpg
Health & Biotech
Health Check: Painchek strives to Make American Aged Folk Comfortable Again
November 20, 2024 | Tim Boreham
https://**promotion blocked**/wp-content/uploads/2024/11/1200-9-300x169.jpg
Health & Biotech
Scott Power: S&P/ASX 200 Health Care Index falls but which stocks are up on positive news?
November 15, 2024 | Nadine McGrath
https://**promotion blocked**/wp-content/uploads/2024/11/1200-7-300x169.jpg
Health & Biotech
Five ASX healthcare companies poised for game-changing catalysts
November 13, 2024 | Nadine McGrath
https://**promotion blocked**/healt...-a-drug-expansion-drive-generically-speaking/ -
Share
No doubt about it Dutes, the rats with the gold teeth have achieved "dog" status at long last, altho the volume is a bit piddly.
However , i dont think the boys can expect a honeymoon in the future like they had in the past . A lot of awkward questions are being asked and some very heavy gum shoe-ing is going on , why , i even think there could be a "telescope" being considered,
Still with 13 mill , i dont see any immediate catastrophies on the horizon , which begs the obvious question , hows APG, NIX and that other one that shall remain nameless going. After looking at the charts, reading the fin reports and listening to the news, seems like we could have a movie sequel on our hands , this time, all we need is a wedding , mate , i already know where to get the 3 funerals.
Cheers
OI NQ , how they hanging?
- *Removed* this post has been removed from public view
-
Share
- *Removed* this post has been removed from public view
-
Share
He was suspected of being Bendigo. Maybe the mods worked it out.
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:27 - 236 reads
Posted by diatribe
IP 203.51.xxx.xxx
Post #529197 - in reply to msg. #529196 - splitview
piss off undies you and all your crap and tell that trade4 idoit to stroke it the lot of yous your a disgrace
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:29 - 236 reads
Posted by bigdump
IP 210.49.xxx.xxx
Post #529199 - in reply to msg. #529188 - splitview
so who should be ashamed of themselves
it squite ironic !
Isn't talking to ones self a form of madness
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:30 - 246 reads
Posted by diatribe
IP 203.51.xxx.xxx
Post #529201 - in reply to msg. #529199 - splitview
fark u 2 fool ramper
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:35 - 242 reads
Posted by trade4profit
IP 144.139.xxx.xxx
Post #529204 - in reply to msg. #529197 - splitview
diatribe...
Here are the posts you refer to "6 - 8 weeks ago"...
---
Subject copper strike.. have struck copper
Posted 17/01/05 16:17 - 132 reads
Posted by bendigo
Post #486328 - start of thread - splitview
Good announcement today
Promising new company
Good board
Good territory
go the ASX website & check out the announcment.
Cheers
Bendigo
---
Subject re: copper strike.. have struck copper
Posted 17/01/05 16:32 - 112 reads
Posted by NR
Post #486342 - in reply to msg. #486328 - splitview
all ready on them bendigo......awaiting further annonucements.......
---
Subject re: copper strike.. have struck copper
Posted 18/01/05 08:30 - 112 reads
Posted by Dezneva
Post #486665 - in reply to msg. #486328 - splitview
Yep, I agree. I know the people as well. They have a whole heap of old TEC ground. Its a great hit. and I think they are continuing the drilling.
---
These were the first 3 posts ever on CSE.
Although Dezneva only posted "...I know the people as well...", I can see how you may have remebered that as "...the boss being a good bloke..."
Problem is, it was Bendigo he was replying to and not you!
How do you explain that?
Cheers!
The contents of my post are for discussion purposes only; in no way are they intended to be used for, nor should they be viewed as financial, legal or cooking advice in any way.
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:40 - 234 reads
Posted by Rocker
IP 220.253.xxx.xxx
Post #529215 - in reply to msg. #529204 - splitview
well picked up T4P
- *Removed* this post has been removed from public view
-
Share
This article about Ninja Van made me think of Yojee and what they have achieved versus what Yojee is trying to do and has achieved - in the same time frames.
https://www.cnbc.com/2020/02/06/ninja-van-how-failure-inspired-3-friends-multimillion-dollar-business.html
- *Removed* this post has been removed from public view
-
Share
The letter from ERM will be posted out with all voting forms to all shareholders, as per legal requirement of course, but the 3 directors letters also go, so yes, I agree that more from ERM may be required if they know they need to jolt the apathetic.
Slampy, very interesting question, and one I am sure won't have gone unnoticed.
Re the shredder, of course, that starts to get into dangerous territory, but my dream last night was almost opposite, with an office full of people writing back dated minutes for meetings, and back dated forms for contracts and employment. It was a hectic dream, and I hope there's no reality in it at all.
- *Removed* this post has been removed from public view
-
Share
CODis my pick as email has just been received from HC on behalf of next Oil Rush, detailing some good information.
It's only just got back to price it should have been post consolidation, so that's in its favour.
Very little to sell, I like that, as it will move quickly.
Many won't have received the email yet as they're at work, etc.
Read more here.
http://www.nextoilrush.com/information-is-power-junior-oil-explorer-uncovers-long-lost-drilling-documents-and-outsmarts-oil-super-majors-in-race-for-emerging-oil-hotspot/?utm_source=HCMO
Looks good for next week. Be prepared!- *Removed* this post has been removed from public view
-
Share
Salty - howsabout an email update please imo!!- *Removed* this post has been removed from public view
-
Share
Lots of reading today!
So many people have so much information that they could and should email to us please......
[email protected]
- *Removed* this post has been removed from public view
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.747M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $5.562K | 292.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 381825 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 60000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 331825 | 0.019 |
3 | 381800 | 0.018 |
1 | 175000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 60000 | 2 |
0.021 | 177000 | 1 |
0.022 | 18000 | 1 |
0.023 | 73278 | 3 |
0.024 | 254102 | 7 |
Last trade - 15.04pm 20/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |